FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)

View source ↗

Summary

FDA notice of a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc., indicating an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

SUPPL AP for ARICEPT (DONEPEZIL HYDROCHLORIDE)